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Abstract
Background: Esophageal submucosal hematoma is a rare complication after endovascular surgery. We report a
case of an esophageal submucosal hematoma which may have been caused by rigorous cough during extubation.
Case presentation: A 75-year-old woman underwent endovascular treatment for unruptured cerebral aneurysm
under general anesthesia. The patient received aspirin and clopidogrel before surgery and heparin during surgery.
Activated clotting time was 316 s at the end of surgery. Protamine was not administered and continuous infusion
of argatroban was started after surgery. She had a rigorous cough during removal of the tracheal tube and reported
retrosternal discomfort postoperatively. She developed hemorrhagic shock after massive hematemesis. A diagnosis of
esophageal submucosal hematoma was made by endoscopic examination and computed tomography. Hemostasis
was achieved by compression with a Sengstaken-Blakemore tube and endoscopic cauterization. Blood pressure was
recovered by blood transfusion. Endoscopic examination performed 7 days after surgery showed that esophageal
submucosal hematoma had almost disappeared and slough had adhered to the mucosal laceration. The patient
showed good recovery and was discharged 21 days after surgery.
Conclusions: Careful extubation and postoperative observation are required in patients receiving antiplatelet and
anticoagulant therapy.
Keywords: Esophageal submucosal hematoma, Coil embolization, Cerebral aneurysm, Antiplatelet and anticoagulant
therapies, Cough during tracheal extubation
Background
Esophageal submucosal hematoma is a rare condition
[1]. Previous reports showed that it may develop after
endovascular surgery, which requires postoperative
anticoagulation therapy. Chest pain is the most frequent
complaint [2], which often misleads a diagnosis such as
ischemic heart disease and aortic dissection. We report a
case who had hematemesis and developed hemorrhagic
shock after endovascular surgery for unruptured cerebral
aneurysm under general anesthesia. Prompt endoscopic
examination enabled early diagnosis and successful
treatment. We discuss the causes of and potential pre-
ventive strategies for esophageal submucosal hematoma
as well as important reminders at the time of onset and
diagnosis and postoperative management. We obtained
written informed consent from the patient to publish
this case report.
Case presentation
A 75-year-old woman (154 cm, 49 kg) underwent coil
embolization of an unruptured cerebral aneurysm under
general anesthesia. Her medical history and preoperative
complications were unremarkable. Preoperative labora-
tory data were within normal limits, with no coagulation
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abnormalities. Aspirin 200 mg and clopidogrel 300 mg,
and aspirin 100 mg and clopidogrel 75 mg were admin-
istered orally on the day before, and in the morning of
the day of surgery, respectively.
General anesthesia was induced with target-controlled
infusion of propofol and remifentanil 0.5 μg/kg/min.
After infusion of rocuronium 50 mg, tracheal intubation
was performed uneventfully, followed by smooth inser-
tion of a nasogastric tube, which was left open to room
air until the completion of surgery, and there was no
spontaneous reflux of gastric contents. Anesthesia was
maintained with target-controlled infusion of propofol
and remifentanil 0.1 μg/kg/min with an inhalational oxy-
gen concentration of 37% under standard monitoring as
well as direct radial artery pressure monitoring. Blood
pressure and heart rate were stable with continuous in-
fusion of phenylephrine 0.4–0.5 mg/h.
Heparin 400 units were intravenously administered at
the beginning of surgery, followed by 500 units during
surgery. Activated clotting time (ACT) was 141, 238,
275, and 316 s before and 5 and 40 min after starting
surgery, at the end of surgery. Protamine was not ad-
ministered. Continuous infusion of argatroban 0.8 μg/
kg/min was started on completion of surgery.
Fentanyl 100 μg was administered 10 min before sur-
gery completion, and continuous infusion of propofol,
remifentanil, and phenylephrine was discontinued at the
completion of surgery. The patient started to wake
5 min after the completion of surgery, and her systolic
blood pressure increased to 160 mmHg and pulse rate
to 90 bpm. The nasogastric tube was removed without
applying negative pressure after aspirating a small
amount of gastric fluid not containing apparent blood
components. Sputum was seen in the tracheal tube,
which was suctioned. Following this, the patient had a
stronger cough. The tracheal tube was removed 12 min
after the completion of surgery after confirming recovery
of consciousness. After extubation, there was no nausea,
vomiting, or strong cough. The patient was stable with a
blood pressure of 140/60 mmHg and pulse rate of
around 90 bpm, and returned to the ICU 20 min after
extubation. Total operative time was 75 min, and total
anesthesia time was 130 min.
The patient started to complain of retrosternal dis-
comfort 24 min after return to the ICU. At that time, her
blood pressure was 140/60 mmHg and pulse rate was
around 90 bpm. The patient started to complain of nausea
48 min after returning to the ICU. Her systolic blood
pressure decreased to 70 mmHg 51 min after returning to
the ICU, and the patient had a hematemesis of ap-
proximately 200 g of fresh blood. And, the ACT was 280 s.
An upper gastrointestinal endoscope was inserted immedi-
ately to identify the bleeding point and achieve hemostasis,
which showed submucosal thickening extending from the
midesophagus to the esophagogastric junction, which was
due to the submucosal hematoma (Fig. 1a: endoscopic
image). At the esophagogastric junction, the esophageal
mucosa was being displaced into the gastric cavity by the
submucosal hematoma (Fig. 1b: endoscopic image). There
was a bleeding laceration in part of the mucosa, for which
pressure hemostasis was performed with a Sengstaken-
Blakemore tube. Continuous infusion of argatroban was
discontinued and protamine was administered, and the
ACT decreased to 126 s. During the endoscopic examin-
ation, the submucosal hematoma was extending toward the
oral side, and it became a hematoma extending from the
esophagogastric junction to the oral cavity at the end of the
endoscopic procedure. The hematemesis continued, and
the amount of bleeding reached 900 g, and the level of
hemoglobin decreased to 7.5 g/dL. A plain computed tom-
ography (CT) was performed to assess the extent of the
hematoma, which showed dilatation of the entire esopha-
gus and the soft tissue shadow filled on the dorsal side that
was ventrally displacing the lumen (Fig. 2a: CT sagittal
Fig. 1 Upper gastrointestinal endoscopy images immediately after hematemesis. a A longitudinal extension of reddish or wine-colored mucosal
thickening (asterisk), obstructing the esophagus, is seen from the midesophagus to the esophagogastric junction. b The submucosal hematoma
(two asterisks) is displacing the esophageal mucosa (asterisk) toward the gastric cavity at the esophagogastric junction. A part of the displaced
mucosa has a laceration with bleeding
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section). These findings, along with the endoscopy re-
sults, were consistent with the diagnosis of esophageal
submucosal hematoma. An isodense area suggesting
hematoma was also observed in the gastric cavity. In
addition, the dilated cervical esophagus was displacing
the trachea (Fig. 2b: CT cross-section). Considering that
the patient would have a greater risk of aspirating
blood into the trachea if the hematoma ruptured,
therefore, we performed tracheal intubation. Observa-
tion during the tracheal intubation showed edema at
the arytenoid region. After compression with the
Sengstaken-Blakemore tube for 1 h, hemostasis was
achieved by cauterizing some parts of the mucosal
laceration at the esophagogastric junction using the
upper gastrointestinal endoscope. Up to this point,
the patient was given fluid resuscitation for the de-
creased blood pressure due to the hemorrhage and
was transfused with 10 units of red blood cells and
2 units of fresh frozen plasma.
The patient was fasted and started on omeprazole
40 mg/day; antiplatelet therapy was discontinued. Upper
gastrointestinal endoscopy performed on the day after
surgery confirmed the absence of expansion of the
hematoma or recurrent bleeding. Neck and thoracic
plain CT performed 4 days after surgery showed reduced
dilatation of the esophagus and improvement in
displacement of the trachea, and thus the tracheal tube
was removed 5 days after surgery. Upper gastrointestinal
endoscopy performed 7 days after surgery showed that
the esophageal submucosal hematoma had almost disap-
peared and the slough had adhered to the mucosal la-
ceration at the esophagogastric junction (Fig. 3). Oral
intake was resumed on the same day. The patient
showed good recovery and was discharged 21 days after
surgery. The patient did not develop thrombotic compli-
cations until discharge, although she did not receive
antiplatelet or anticoagulant therapy.
Esophageal submucosal hematoma is a rare condition in
the spectrum of esophageal injury including Mallory-
Weiss syndrome and Boerhaave syndrome [3]. These
conditions are similar in that they are induced by a sudden
increase in esophageal pressure. While Mallory-Weiss
syndrome and Boerhaave syndrome are usually associated
with vomiting, patients with esophageal submucosal
hematoma do not always present with vomiting [3, 4].
Classification of the causes of esophageal submucosal
hematoma into idiopathic (spontaneous) and traumatic
has originally reported by Freeman AH [2]. The idiopathic
causes of esophageal submucosal hematoma include a
sudden increase in the esophageal pressure not only by
vomiting or vomiting reflex but also by coughing and
sneezing. Sometimes, the causes are unknown [3–5]. The
traumatic causes of esophageal submucosal hematoma
include direct or blunt injury caused by medical apparatus
inserted into the esophagus [6], insertion of gastric tube
[7], and accidental swallowing of foreign objects. Most
reported cases with esophageal submucosal hematoma
were of patients receiving antiplatelet drugs or who had
abnormal coagulation [6–8]. Therefore, bleeding tendency
is a contributing factor to the aggravation of esophageal
submucosal hematoma [5].
In the present case, the patient had a stronger cough
during the period from the time when the patient woke
up from general anesthesia to the time of extubation of
the tracheal tube, especially when we suctioned sputum
from the tracheal tube. We considered that an increased
abdominal pressure due to the cough led to elevated
esophageal pressure that could be a cause of the eso-
phageal submucosal dissection or esophageal mucosal
injury. During the upper gastrointestinal endoscopic
examination performed immediately after hematemesis,
the submucosal hematoma was observed to be extending
toward the upper esophagus with repeated hematemesis,
suggesting that the elevated esophageal pressure was the
Fig. 2 Cervical and thoracic CT images after insertion of Sengstaken-Blakemore tube. a Sagittal section: the soft tissue shadow is filled and dilatation
can be seen in the posterior wall over the entire length of the esophagus (red arrows), ventrally displacing the lumen. b Cross-section: the cervical
esophagus is dilated, displacing the trachea toward the left side
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primary cause of the esophageal submucosal hematoma
and its expansion in the present case. Although cough is a
rare cause of esophageal submucosal hematoma, Cao et
al. reported a case of esophageal submucosal hematoma
occurring after persistent coughing for 1 week in a patient
with viral bronchitis [5].
The nasogastric tube was inserted into the stomach after
introducing general anesthesia and left open to room air.
Direct damage to the mucosa by the nasogastric tube was
considered unlikely, because the tube had been inserted
into the stomach without resistance and that bloody se-
cretion had not been aspirated from the tube before extu-
bation. Fujimoto et al. reported a case of esophageal
submucosal hematoma possibly caused by gastric tube
removal with sustained negative pressure [7]. In the
present case, aspiration was performed only once before
extubation. However, if the tube had been placed around
the esophagogastric junction, mucosal injury due to as-
piration might have caused the submucosal hematoma.
In general, when performing coil embolization for an
unruptured cerebral aneurysm, antiplatelet therapy is
started preoperatively and anticoagulant therapy is started
intraoperatively to prevent thrombotic complications [9,
10], However, as there are no established guidelines for pre-
ventive treatment, the methods vary between institutions
and according to morphology of aneurysms. In our depart-
ment of neurosurgery, we use two antiplatelet drugs in
combination, we administer heparin during surgery to
maintain an ACT of 200 s or longer, and we perform con-
tinuous infusion of argatroban for 48 h after surgery as
anticoagulant therapy. We compared the use of anticoagu-
lant therapy in the present case with that in two previously
reported cases of esophageal submucosal hematoma after
coil embolization for unruptured cerebral aneurysm [7]. Re-
garding antiplatelet drugs, one patient used aspirin [7],
while the other used aspirin and clopidogrel in the same
combination [1] as was used in the present case. Regarding
anticoagulant therapy, the initial dose of heparin and ACT
during surgery were similar in the three cases; however, the
ACT at the completion of surgery was longer in the present
case (316 s) than in the other two cases (239 and 265 s, re-
spectively), and the continuous infusion of argatroban was
performed only in the present case. Therefore, relatively in-
tensive antithrombotic therapy performed in the present
case was considered to have an influence on the occurrence
of extensive submucosal hematoma of the esophagus and
subsequent massive hematemesis with hemorrhagic shock.
Hematemesis, as a symptom of esophageal submucosal
hematoma, results from rupture of the most vulnerable
part of the mucosa due to expansion of the hematoma [6].
The bleeding point in the present case was the lower part
of the esophagus. Anatomically, the mucosa of the lower
part of the esophagus is prone to injury under the influ-
ence of intrathoracic or esophageal pressure [5]. In the
present case, it was considered that the mucosa of the
lower part of the esophagus became fragile and ruptured
due to an increased pressure by coughing at the time of
extubation. In esophageal submucosal hematoma, the
amount of hematemesis is usually small. Shim et al. re-
ported that, among 119 patients with esophageal sub-
mucosal hematoma reported since 1968, 11 had more
than 500 g hematemesis with hypotension or bleeding that
required transfusion of at least 4 units [4].
The present study suggests that coughing at the time of
extubation can be a cause of esophageal submucosal
hematoma or mucosal rupture. Therefore, clinicians
should be very careful about the risk of esophageal sub-
mucosal hematoma, especially when treating patients re-
ceiving antiplatelet or anticoagulant therapy under general
anesthesia. We retrospectively considered that we could
have reduced cough if we had suctioned the sputum in
the tracheal tube under deep anesthesia. In addition, the
use of nasogastric tube should be carefully considered, be-
cause its insertion and removal is associated with risk.
Conclusions
The prognosis of esophageal submucosal hematoma is
good. However, patients receiving antiplatelet or anti-
coagulant therapy have a risk of massive bleeding that
requires urgent treatment. Clinicians should be aware
of the risk of esophageal submucosal hematoma in
postoperative management of patients undergoing coil
embolization for cerebral aneurysm.
Fig. 3 Upper gastrointestinal endoscopy image 7 days after
surgery. The esophageal submucosal had almost disappeared,
and the slough had adhered to the mucosal laceration at
the esophagogastric junction
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